Unlocking New Frontiers

Pioneering Rare Indication Trials with AI-powered Study Feasibility

Available on Thursday, May 23rd 

Register for our upcoming webinar

Lorem ipsum is simply printer galley known printer

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

  • Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's
  • Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's

Sign up today to receive a copy of the webinar on May 23rd!

Join us as we explore the integration of AI-powered study feasibility within rare indication trials. Discover the unique hurdles faced when conducting trials for rare indications and unravel how AI-driven study feasibility is poised to revolutionize this complex landscape.

Otis Johnson

 

Otis Johnson

Principal Consultant

Trial Equity

Mo Ali

 

 

Mo Ali

Head of Reporting  Analytics & Insights

Astellas

Rohit Nambisan 2023 in round Lokavant frame with white background

Rohit Nambisan

CEO 

Lokavant

michelleeverillhalo

 

 

 

Michelle Everill

Former Head of Clinical Business Operations

BMS 

Webinar

Unlocking New Frontiers: Pioneering Rare Indication Trials with AI-powered Study Feasibility
  • calendar. 1

    Thursday, May 23rd 2024

  • time 2

    On-Demand

Presented by industry experts Rohit Nambisan from Lokavant, Otis Johnson with Trial Equity, and Mo Ali from Astellas, and Michelle Everill former BMS. This webinar will include: 

  • Market trends driving more rare indication trials and the need for more complex feasibility in the study planning process.
  • How to leverage and link Real-World Data (RWD) to clinical trials outcomes, past site performance and patient enrollment factors; to anticipate trial operations and mitigate risks before sites are even selected.
  • How to incorporate real-time enrollment management and forecasting, to enable study teams to know if their trials are on-target or at-risk, and compare new study scenarios to understand the impact on trial timelines and odds-of-success.

Whether you're a researcher, clinician, or industry professional, this webinar will offer you valuable perspectives on the future of rare disease research and the pivotal role of AI in driving innovation. Don't miss this opportunity to gain insights, exchange ideas, and be at the forefront of pioneering advancements in rare indication trials.

form-logo
Register for our Webinar